Cargando…

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections

Persistent high-risk human papillomavirus (HPV) infection is strongly associated with the development of high-grade cervical intraepithelial neoplasia (CIN) or cancer. Not all persistent infections lead to cancer. Viral load measured at a single time-point is a poor predictor of the natural history...

Descripción completa

Detalles Bibliográficos
Autores principales:	Depuydt, Christophe E, Jonckheere, Jef, Berth, Mario, Salembier, Geert M, Vereecken, Annie J, Bogers, Johannes J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559041/ https://www.ncbi.nlm.nih.gov/pubmed/25991420 http://dx.doi.org/10.1002/cam4.473

Ejemplares similares

Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin
por: Depuydt, CE, et al.
Publicado: (2016)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV‐1 in Lao People's Democratic Republic
por: Paboriboune, Phimpha, et al.
Publicado: (2022)

Geographical disparities in human papillomavirus herd protection
por: Berenson, Abbey B., et al.
Publicado: (2020)

Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high‐risk HPV‐positive women
por: Chen, Xiaojun, et al.
Publicado: (2019)

The potential population‐based impact of an HPV vaccination intervention in Colorado
por: Cataldi, Jessica R., et al.
Publicado: (2019)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

Current trends in the etiology and diagnosis of HPV-related head and neck cancers
por: Chai, Ryan C, et al.
Publicado: (2015)

Missed opportunities for concomitant HPV vaccination among childhood cancer survivors
por: Ramsay, Joemy M., et al.
Publicado: (2022)

Quality control for normal liquid-based cytology: Rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?
por: Depuydt, Christophe E, et al.
Publicado: (2009)

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland
por: Lehtinen, Matti, et al.
Publicado: (2021)

Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women
por: Depuydt, C E, et al.
Publicado: (2003)

A systematic review of the HPV‐attributable fraction of oropharyngeal squamous cell carcinomas in Germany
por: Reuschenbach, Miriam, et al.
Publicado: (2019)

The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications
por: Hu, Zheng, et al.
Publicado: (2018)

Negative Impact of Elevated DNA Fragmentation and Human Papillomavirus (HPV) Presence in Sperm on the Outcome of Intra-Uterine Insemination (IUI)
por: Depuydt, Christophe, et al.
Publicado: (2021)

Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women
por: Johnson, Lauren G., et al.
Publicado: (2020)

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
por: Ma, Mingjun, et al.
Publicado: (2022)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
por: Duan, Rufei, et al.
Publicado: (2019)

Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage
por: Wang, Min, et al.
Publicado: (2021)

At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV
por: Abulizi, Guzhalinuer, et al.
Publicado: (2021)

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection
por: Vriend, Henrike J, et al.
Publicado: (2015)

The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women
por: Zhu, Bo, et al.
Publicado: (2019)

Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies
por: Auguste, Aviane, et al.
Publicado: (2020)

Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high‐risk human papillomavirus cervical carcinomas
por: Liu, Jing Jing, et al.
Publicado: (2020)

Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer
por: Huang, Cheng‐Chih, et al.
Publicado: (2021)

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach
por: Kunckler, Margot, et al.
Publicado: (2017)

HPV‐vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level
por: Altobelli, Emma, et al.
Publicado: (2019)

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
por: Rosillon, Dominique, et al.
Publicado: (2019)

Changes in type-specific human papillomavirus load predict progression to cervical cancer
por: Depuydt, Christophe E, et al.
Publicado: (2012)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age
por: Schwarz, Tino F., et al.
Publicado: (2017)

A cross‐sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women
por: Wu, Qiongyan, et al.
Publicado: (2017)

Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns
por: Fokom Domgue, Joël, et al.
Publicado: (2020)

Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China
por: Wang, Yuli, et al.
Publicado: (2018)

A public health approach to cervical cancer screening in Africa through community‐based self‐administered HPV testing and mobile treatment provision
por: Nakalembe, Miriam, et al.
Publicado: (2020)

Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
por: Clarke, Megan A., et al.
Publicado: (2021)

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants
por: Madeleine, Margaret M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o33op2cukv9iu15vbn7688sflj